Kevin Kissane

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT.

Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products.

Spacelabs Healthcare, Inc. manufactures and distributes medical devices and services. It offers cardiology and remote monitoring, cybersecurity, and supplies and accessories. The company was founded by Ben L. Ettelson and James A. Reeves in 1958 and is headquartered in Snoqualmie, WA.

Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.

Eschmann Holdings Ltd. designs and manufactures medical equipment. Its products include powered operating tables, operating table accessories, specialist operating tables, operating theatre lighting systems, surgical suction units, benchtop autoclaves, electrosurgery units, and accessories such as smoke evacuation units, monopolar and bipolar forceps, scissors and electrodes. The company was founded in 1830 and is headquartered in Lancing, the United Kingdom.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

Biosurfit SA offers vitro diagnostics solutions. It product spinit is a fully automated diagnostics solution designed to deliver blood analysis information to physicians in minutes. The company was founded by Joao Manuel de Oliveira Garcia da Fonseca in 2006 and is headquartered in Lisbon, Portugal.

RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.

Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The company is based in Lincoln, NE.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937.

Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom.

Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB.

Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY.

Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom.

Part of GSK Plc, GlaxoSmithKline Research & Development Ltd. is a British biopharma company that unites science, technology, and talent to get ahead of disease together. The company was founded in 1965 and is based in Brentford, UK. GSK's work in HIV is carried out entirely through ViiV Healthcare, which GSK majority owns with Pfizer and Shionogi as shareholders. The company is united to do better in various fields, from finance to communications, procurement to HR. GSK provides images and B-roll video for media use and has a privacy notice that applies to any individual who is a current or former registered shareholder of GSK plc.

Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom.

Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China.

Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom.

Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.

TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom.

Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH.

Israel Cancer Research Fund operates as a charitable organization. The non-profit company is based in New York, NY.

XO1 Ltd. develops a novel anticoagulant drug. The firm operates as a biopharmaceutical company. The company was founded by David J. Grainger on February 28, 2013 and is headquartered in High Wycombe, the United Kingdom.

Stowheath Ltd. is a British company that provides professional, scientific, and technical services. The private company is based in London, UK. The company was founded in 2011.

Concepta Diagnostics Ltd. engages in the development of products for the female health diagnostics sector. The company was founded by Steven Koon Ching Lee and Robert Andrew Porter on January 15, 2013 and is headquartered in Cardiff, the United Kingdom.

Delta Diagnostics Ltd. develops and provides assays diagnostics solutions. It offers cystic fibrosis, rapid aneuploidy analysis, and genetic disease diagnosis. The company was founded in 1994 and is headquartered in Lancashire, the United Kingdom.

Part of STERIS Plc (Ireland), Eschmann Technologies Ltd. is a British manufacturer that provides medical products and services to clinical professionals worldwide. The company is based in Lancing, UK, and manufactures autoclaves and surgical suction devices. Eschmann specializes in infection control workflows and efficiencies, disinfection, sterilization, and decontamination. Eschmann's trustworthy range of products is available to purchase online, and the British company provides excellent customer support and service. The company was founded in 1830 and has over 190 years of continuous innovation.

Revona Bio Ltd. is a British biotechnology company that specializes in the development of RNA targeted drugs. The company was founded in 2022 by Anastasia Jane Callaghan and Charlotte Anne Henderson.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.